“The Stakes Are Higher”- Patient and Caregiver Perspectives on Cystic Fibrosis Research and Personalized Medicine

Introduction Making bench to bedside advances in cystic fibrosis (CF) care requires the sustained engagement and trust of people living with CF. However, there is a scarcity of studies exploring their concerns and priorities regarding research and its end products. The aim of this qualitative study was to generate empirical evidence regarding patient and caregiver perspectives on cystic fibrosis research and personalized medicine to foster developments in translational research in Canada. Methods A total of 15 focus groups were conducted, engaging 22 adults with CF and 18 caregivers (e.g., parents, siblings and partners) living in Canada. Inductive thematic analysis relied on an iterative process involving themes derived from both participant meaning-making and existing scientific literature. Participant perspectives were considered along intrapersonal, intracommunity, interpersonal, and structural lines. Results Overall, participants described a relationship to CF research inextricable from the lived experience of CF as a lifelong progressive and terminal disease and from the goal of advancing medical science. They were enthusiastic and excited about the emergence of CFTR modulators, although they had some knowledge gaps regarding the associated research. They largely spoke to positive experiences with researcher communication but had feedback regarding informed consent processes and the return of study results. Participants also voiced concerns about structural access barriers to research and to its end products. Extensive histories of research participation, a relatively small and intercommunicative CF community, and structural overlap between research and care settings contributed to their perspectives and priorities. Conclusion Study findings are valuable for researchers and policy-makers in CF and rare or progressive diseases more broadly. Continuing to solicit and listen to the voices of patients and caregivers is crucial for research ethics and the translation of new therapies in the area of personalized medicine.

[1]  B. Knoppers,et al.  The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada , 2021, Journal of personalized medicine.

[2]  A. Bredenoord,et al.  Mini-gut feelings: perspectives of people with cystic fibrosis on the ethics and governance of organoid biobanking. , 2021, Personalized medicine.

[3]  S. McColley,et al.  Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype , 2021, Pediatric pulmonology.

[4]  M. Isaacson,et al.  The Dance of Cystic Fibrosis: Experiences of Living with Cystic Fibrosis as an Adult. , 2020, Journal of clinical nursing.

[5]  John H. Evans,et al.  Self-Interested and Altruistic Motivations in Volunteering for Clinical Trials: A More Complex Relationship , 2020, Journal of empirical research on human research ethics : JERHRE.

[6]  M. Lopes-Pacheco.  CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine , 2020, Frontiers in Pharmacology.

[7]  Andrea Martani,et al.  Structural racism in precision medicine: leaving no one behind , 2020, BMC Medical Ethics.

[8]  S. McColley,et al.  The demographics of adverse outcomes in cystic fibrosis , 2019, Pediatric pulmonology.

[9]  Wei Zheng,et al.  Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids. , 2019, Drug discovery today.

[10]  Jeong-Soo Hong,et al.  Cystic fibrosis precision therapeutics: Emerging considerations , 2019, Pediatric pulmonology.

[11]  L. Saiman.  Improving outcomes of infections in cystic fibrosis in the era of CFTR modulator therapy , 2019, Pediatric pulmonology.

[12]  B. Sweet.  Emerging Considerations , 2019, Thinking Outside the Voice Box.

[13]  D. E. Tullis,et al.  Improving dissemination of study results: perspectives of individuals with cystic fibrosis , 2019, Research Ethics.

[14]  B. Knoppers,et al.  Return of individual genomic research results: are laws and policies keeping step? , 2019, European Journal of Human Genetics.

[15]  S. Stanojevic,et al.  The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[16]  T. Caulfield,et al.  Fake news portrayals of stem cells and stem cell research. , 2017, Regenerative medicine.

[17]  E. Nash,et al.  The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers , 2017, Thorax.

[18]  W. Lieb,et al.  Broad consent for health care–embedded biobanking: understanding and reasons to donate in a large patient sample , 2017, Genetics in Medicine.

[19]  D. E. Tullis,et al.  The Meanings of Helping: An Analysis of Cystic Fibrosis Patients’ Reasons for Participating in Biomedical Research , 2017, Journal of empirical research on human research ethics : JERHRE.

[20]  J. Rommens,et al.  Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia , 2017, npj Genomic Medicine.

[21]  S. Fullerton,et al.  Genomics is failing on diversity , 2016, Nature.

[22]  G. Oates,et al.  Socioeconomic status and health outcomes: cystic fibrosis as a model , 2016, Expert review of respiratory medicine.

[23]  I. Budin-Ljøsne,et al.  Patient and interest organizations’ views on personalized medicine: a qualitative study , 2016, BMC Medical Ethics.

[24]  M. Harrison.  A Global Perspective , 2015, Bulletin of the history of medicine.

[25]  V. Waters,et al.  How Do Young People with Cystic Fibrosis Conceptualize the Distinction Between Research and Treatment? A Qualitative Interview Study , 2015 .

[26]  L. Thabane,et al.  Innovations in Research with Medically Fragile Populations: Using Bulletin Board Focus Groups , 2014 .

[27]  L. Saiman,et al.  Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update , 2014, Infection Control & Hospital Epidemiology.

[28]  I. Balfour-Lynn.  Personalised medicine in cystic fibrosis is unaffordable. , 2014, Paediatric respiratory reviews.

[29]  G. Magazzù,et al.  282 Patient priorities for research in cystic fibrosis: the IPaCOR experience , 2014 .

[30]  S. Peacock,et al.  Methodological Reflections on the Use of Asynchronous Online Focus Groups in Health Research , 2012 .

[31]  M. W. Lensch.  Public perception of stem cell and genomics research , 2011, Genome Medicine.

[32]  M. Jessup,et al.  “All at Sea”: The Experience of Living With Cystic Fibrosis , 2010, Qualitative health research.

[33]  N. Hallowell,et al.  An investigation of patients’ motivations for their participation in genetics-related research , 2009, Journal of Medical Ethics.

[34]  L. Patterson.  Narrative Methods for the Human Sciences , 2008 .

[35]  P. Sainsbury,et al.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[36]  K. Glanz,et al.  An Ecological Perspective on Health Promotion Programs , 1988, Health education quarterly.

[37]  B. Ramsey,et al.  The Changing Face of Cystic Fibrosis , 2020 .

[38]  C. Goss,et al.  The future of cystic fibrosis care: a global perspective. , 2020, The Lancet. Respiratory medicine.

[39]  L. Kazembe,et al.  Leaving No One Behind , 2021, Adolescents in Humanitarian Crisis.

[40]  C. Goss,et al.  Cystic fibrosis , 2015, Nature Reviews Disease Primers.

[41]  Steven N Goodman,et al.  The research-treatment distinction: a problematic approach for determining which activities should have ethical oversight. , 2013, The Hastings Center report.

[42]  J. Sallis,et al.  Ecological models of health behavior. , 2008 .

[43]  K. Shadan,et al.  Available online: , 2012 .

[44]  P. Cardon,et al.  A qualitative study. , 2001 .

[45]  Janet Mancini Billson,et al.  Focus Groups: A Practical Guide for Applied Research , 1989 .

[46]  U. Bronfenbrenner.  Toward an Experimental Ecology of Human Development. , 1977 .